NO20021310L - amine derivatives - Google Patents

amine derivatives

Info

Publication number
NO20021310L
NO20021310L NO20021310A NO20021310A NO20021310L NO 20021310 L NO20021310 L NO 20021310L NO 20021310 A NO20021310 A NO 20021310A NO 20021310 A NO20021310 A NO 20021310A NO 20021310 L NO20021310 L NO 20021310L
Authority
NO
Norway
Prior art keywords
amine derivatives
treatment
ring
well
phosphodiesterase
Prior art date
Application number
NO20021310A
Other languages
Norwegian (no)
Other versions
NO20021310D0 (en
Inventor
Volker Eiermann
Rochus Jonas
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20021310D0 publication Critical patent/NO20021310D0/en
Publication of NO20021310L publication Critical patent/NO20021310L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Aminderivater med formel (I] R1 (l) samt deres fysiologisk akseptable salter og solvater, hvor R1, R2, R8, R9, R10, R11, Q, X, Y, Z, r og ringen A samt ringen C har de i krav l angitte betyd- ninger, utviser en fosfodiesterase V- inhibering og kan anvendes til behand- ling av sykdommer i hjerte-blodomløps- systemet og til behandling og/eller terapi av potensforstyrrelser.Amine derivatives of formula (I] R1 (1) as well as their physiologically acceptable salts and solvates, wherein R1, R2, R8, R9, R10, R11, Q, X, Y, Z, r and ring A as well as ring C have the claims In the meanings stated, a phosphodiesterase V inhibition exhibits and can be used for the treatment of diseases of the cardiovascular system and for the treatment and / or therapy of potency disorders.

NO20021310A 1999-09-17 2002-03-15 amine derivatives NO20021310L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944604A DE19944604A1 (en) 1999-09-17 1999-09-17 Amine derivatives
PCT/EP2000/008256 WO2001021620A2 (en) 1999-09-17 2000-08-24 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines

Publications (2)

Publication Number Publication Date
NO20021310D0 NO20021310D0 (en) 2002-03-15
NO20021310L true NO20021310L (en) 2002-03-15

Family

ID=7922374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021310A NO20021310L (en) 1999-09-17 2002-03-15 amine derivatives

Country Status (11)

Country Link
EP (1) EP1212329A2 (en)
JP (1) JP2003509511A (en)
KR (1) KR20020027652A (en)
AU (1) AU7412700A (en)
BR (1) BR0014052A (en)
CA (1) CA2387520A1 (en)
CZ (1) CZ2002817A3 (en)
DE (1) DE19944604A1 (en)
NO (1) NO20021310L (en)
PL (1) PL353319A1 (en)
WO (1) WO2001021620A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148883A1 (en) 2001-10-04 2003-04-10 Merck Patent Gmbh New fused bi- or tricyclic pyrimidine derivatives, are phosphodiesterase V inhibitors useful e.g. for treating impotence, cardiovascular disorders, inflammation or tumors
JPWO2003035653A1 (en) * 2001-10-26 2005-02-10 日本曹達株式会社 Pyridothienopyrimidine compounds and salts thereof
AR059901A1 (en) 2006-03-20 2008-05-07 Bayer Pharmaceuticals Corp USEFUL TETRAHYDROPIRIDOTIENOPIRIMIDINE COMPOUNDS TO TREAT OR PREVENT CELLULAR PROLIFERATIVE DISORDERS.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470356A1 (en) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K New thieno [3,2-d] pyrimidines and process for their preparation
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (en) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidines
DE19819023A1 (en) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidines
US5948911A (en) * 1998-11-20 1999-09-07 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
AU3453900A (en) * 1999-03-30 2000-10-23 Nippon Soda Co., Ltd. Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE19928146A1 (en) * 1999-06-19 2000-12-21 Merck Patent Gmbh New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence

Also Published As

Publication number Publication date
KR20020027652A (en) 2002-04-13
WO2001021620A3 (en) 2001-11-01
EP1212329A2 (en) 2002-06-12
WO2001021620A2 (en) 2001-03-29
JP2003509511A (en) 2003-03-11
CA2387520A1 (en) 2001-03-29
PL353319A1 (en) 2003-11-17
NO20021310D0 (en) 2002-03-15
BR0014052A (en) 2002-05-21
AU7412700A (en) 2001-04-24
DE19944604A1 (en) 2001-03-22
CZ2002817A3 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
NO991951L (en) Tienopyrimidines with phosphodiesterase V inhibitory effect
NO992821L (en) Ketobenzamides as Calpain Inhibitors
NO20021328L (en) Pyrazolopyrimidia as therapeutic agents
NO20002702L (en) thienopyrimidine
GEP20053476B (en) 3(5)-Amino-Pyrazole Derivatives, Process for Their Preparation and Their Use as Antitumor Agents
TR200102042T2 (en) New aralkyl amines useful for the treatment of spiro fropyridines.
NO20052182L (en) New connections
MX9805181A (en) Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives.
NO20016201L (en) Tienopyrimidines as phosphodiesterase inhibitors
NO991761L (en) New piperidine cotocarboxylic acid derivatives, their preparation and use
NO990433L (en) New compounds and compositions for the treatment of diseases associated with tryptase activity
DE50211929D1 (en) Pyrimidinderivate
NO20021083L (en) Pyrazolo [4,3-d] pyrimidines
GB9502644D0 (en) Heterocyclic derivatives
ATE287886T1 (en) USE OF 5-THIO, SULFINYL- AND SULFONYLPYRAZOLO 3,4-B) PYRIDINES AS CYCLINE-DEPENDENT KINASE INHIBITORS
NO20022123L (en) Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII
NO20021503L (en) quinazolinones
NO20001934L (en) 3-Substituted tetrahydropyridopyrimidinone derivatives, their preparation and use
UA42731C2 (en) Arylalkyl-thiadiazinones, process for preparation thereof, pharmaceutical composition, process for preparation thereof and treatment method
NO991734L (en) Pyrazolinones for the treatment of potency disorders
NO20021310L (en) amine derivatives
NO982863L (en) New compounds with analgesic effect
NO20053805L (en) Diarylmethylindenepiperidine derivatives, processes for their preparation, and use thereof
NO971424L (en) Novel heterocyclic substituted imidazoloquinoxalinones, their preparation and use
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application